BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10778651)

  • 1. Treatment and outcome of lupus nephritis at the turn of the millennium.
    Uppal SS
    J Assoc Physicians India; 1999 Sep; 47(9):857-61. PubMed ID: 10778651
    [No Abstract]   [Full Text] [Related]  

  • 2. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis.
    Chan TM
    Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. This house believes that low-dose intravenous cyclophosphamide is superior to standard high-dose regimes for treatment of lupus nephritis.
    Gorman C; Bhatia A; Rahman A
    Rheumatology (Oxford); 2005 Mar; 44(3):398-401. PubMed ID: 15494351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of immunosuppressive drugs in lupus nephritis].
    Klippel JH; Austin HA; Balow JE
    Ter Arkh; 1986; 58(7):109-11. PubMed ID: 2945277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis].
    Saracyn M; Korsak J; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):162-4. PubMed ID: 15603328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How did cyclophosphamide become the drug of choice for lupus nephritis?
    Bargman JM
    Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful pregnancy after cyclophosphamide therapy for lupus nephritis.
    Lannes G; Elias FR; Cunha B; Jesus N; Klumb EM; Albuquerque EM; Ribeiro FM
    Arch Gynecol Obstet; 2011 Mar; 283 Suppl 1():61-5. PubMed ID: 21331538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent clinical trials in lupus nephritis.
    Ward MM
    Rheum Dis Clin North Am; 2014 Aug; 40(3):519-35, ix. PubMed ID: 25034160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lupus patient with nephropathy. Survival is kidney problem].
    MMW Fortschr Med; 2008 Jan; 150(5):17. PubMed ID: 18300547
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of IGA nephritis].
    Risler T; Braun N
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):996. PubMed ID: 11004910
    [No Abstract]   [Full Text] [Related]  

  • 14. A burden to bear in systemic lupus erythematosus (SLE).
    Pussell BA
    Aust N Z J Med; 1998 Aug; 28(4):483-4. PubMed ID: 9777128
    [No Abstract]   [Full Text] [Related]  

  • 15. [Invasive disseminated aspergillosis in combined immunosuppressive therapy in systemic lupus erythematosus].
    Teuber G; Schwarting A; Mildenberger P; Schmidt-Brücken G; Moll R; Bornemann A; Wandel E; Wanitschke R; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1996 Dec; 91(12):798-801. PubMed ID: 9082168
    [No Abstract]   [Full Text] [Related]  

  • 16. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.
    Barbano G; Gusmano R; Damasio B; Alpigiani MG; Buoncompagni A; Gattorno M; Perfumo F
    J Nephrol; 2002; 15(2):123-9. PubMed ID: 12018627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New insight into nephrotic lupus glomerulonephritis].
    Yokoyama H; Okuyama H
    Nihon Jinzo Gakkai Shi; 2010; 52(7):903-7. PubMed ID: 21077339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing treatment for proliferative lupus nephritis.
    Balow JE
    Arthritis Rheum; 2002 Aug; 46(8):1981-3. PubMed ID: 12209498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.